A groundbreaking study recently published in the International Journal of Oral Science uncovers novel molecular subtypes of oral cavity squamous cell carcinoma (OCSCC), particularly emphasizing cases arising in patients with no identifiable traditional risk factors. Head and neck cancers, notably OCSCC, have long been linked to well-established etiologies including tobacco use, alcohol consumption, and infections by oncogenic strains of human papillomavirus (HPV). However, an increasing incidence of OCSCC in younger patients and women devoid of these recognized exposures has puzzled oncologists and molecular biologists alike. This cutting-edge research, led by Dr. Jiri Zavadil at the International Agency for Research on Cancer (IARC) and Prof. François Virard of the Cancer Research Center of Lyon (CRCL), delineates the distinct genomic and epigenomic landscapes of these atypical tumors, thereby enriching our understanding of oral cancer heterogeneity.
The team leveraged expansive datasets from The Cancer Genome Atlas (TCGA) to conduct an extensive multi-omics analysis integrating mutational profiles, gene expression patterns, and epigenetic modifications across 347 curated samples of head and neck cancers. This included 253 oral cavity tumors alongside 94 laryngeal cancers, the latter serving as smoking-related controls. By employing sophisticated computational approaches to identify mutational signatures—characteristic mutation patterns attributable to underlying DNA damage mechanisms—the researchers stratified tumors into biologically coherent clusters. This novel stratification sheds light on the different carcinogenic processes at play and allows for a nuanced classification beyond clinical risk factors.
Central to the study’s findings was the identification of four discrete mutational clusters. Two clusters correlated closely with established etiologic agents such as tobacco and alcohol, marked by mutational signatures SBS4 and SBS16, respectively. Notably, the mutation burden attributed to tobacco exposure was not uniform; laryngeal tumors exhibited a significantly higher number of tobacco-related mutations compared to oral cavity tumors. This variation underscores tissue-specific susceptibility and distinct carcinogenic responses within the aerodigestive tract. This differential mutational landscape hints at unique microenvironmental factors and local tissue biology influencing how carcinogens impact DNA integrity.
Crucially, two distinct clusters emerged that were highly enriched in cases lacking any known risk factor exposure—coined as No Identified Risk Factor (NIRF) OCSCC. These tumors demonstrated signatures predominantly driven by endogenous mutational processes rather than extrinsic carcinogens. The aging-associated SBS1 signature and APOBEC-related signatures, SBS2 and SBS13, were found to underlie the mutational burden of these tumors. APOBEC enzymes, known for cytidine deaminase activity inducing clustered mutations, have been increasingly recognized as intrinsic drivers of somatic mutagenesis in various cancers. Their prominent role in NIRF OCSCC points towards internal mutagenic mechanisms and suggests a paradigm shift in understanding oral carcinogenesis beyond environmental exposures.
In addition to the mutational signature analysis, integrative genomic profiling uncovered distinctive driver gene alterations within the NIRF tumor clusters. These included mutations impacting immune regulatory pathways and critical components of cellular signaling networks. Transcriptional analyses further revealed the activation of antimicrobial and keratinization pathways specific to these tumors. Intriguingly, histopathological assessment identified the presence of bacterial elements within the tumor microenvironment, implicating the oral microbiome as a potentially influential factor in tumorigenesis. While causality remains to be fully elucidated, these findings highlight a novel interface between host immune response, microbial ecology, and cancer biology.
The clinical ramifications of these discoveries are profound. NIRF tumors displayed molecular hallmarks of immune evasion, including perturbations in antigen presentation machinery which are pivotal for immune recognition. Such features could influence responsiveness to immune checkpoint inhibitors, a rapidly evolving class of immunotherapies. Moreover, the APOBEC-driven mutagenesis suggests heightened genomic instability and altered DNA damage repair capacity, making these tumors potentially vulnerable to targeted agents modulating DNA repair pathways. This opens exciting avenues for precision oncology where tailored treatments could be developed for this understudied patient group.
This study challenges the longstanding paradigm that external carcinogen exposure is essential for oral cancer development. Instead, it establishes NIRF OCSCC as a biologically and clinically distinct entity, driven primarily by endogenous mutational processes and potentially influenced by microbial interactions. This refined molecular taxonomy not only enhances diagnostic precision but also propels future research aimed at unraveling novel etiologies, markers, and druggable targets for oral cancer.
Importantly, the research methodology exemplifies the power of integrative multi-omics combined with robust bioinformatics frameworks to dissect cancer complexity. The use of large, publicly available datasets underscores the value of open science in accelerating discoveries with global impact. Moreover, the collaborative synergy between epidemiologists, molecular biologists, and clinicians at IARC and CRCL represents a model for effective translational cancer research.
Looking forward, these insights necessitate a reevaluation of current screening and prevention strategies for oral cancer, especially in populations previously considered low risk. Investigations into the oral microbiome and its interplay with host immunity may uncover modifiable risk factors. Additionally, deeper functional studies on APOBEC enzymes and aging-associated mutations are imperative to identify mechanistic vulnerabilities. Together, these efforts could translate into innovative therapeutic paradigms tailored to the molecular etiology of each tumor subtype.
In conclusion, the elucidation of distinct mutational signatures and molecular features in NIRF oral cancers marks a pivotal advance in oncology. By spotlighting the significance of endogenous mutational processes and their interaction with immune and microbial factors, the study paves the way for a new era of cancer classification and personalized treatment. This represents an inspiring leap toward deciphering the complex biology underlying oral cancer and improving outcomes for patients worldwide. The full details of this transformative study are accessible in the April 2026 issue of the International Journal of Oral Science.
Subject of Research: Human tissue samples
Article Title: Mutational signature-based classification uncovers emerging oral cancer subtypes with distinct molecular patterns
News Publication Date: 24-Apr-2026
References: DOI: 10.1038/s41368-026-00437-4
Image Credits: Luca Pastore, Maria Luisa Fiorella, Raffaele Fiorella, Lorenzo Lo Muzio from Openverse
Keywords: Oral cancer, mutational signatures, APOBEC, squamous cell carcinoma, head and neck cancer, genomics, epigenetics, oral microbiome, immune evasion, endogenous mutagenesis, aging signature, precision oncology
